Tier 2 · Liquid 3000

Akebia Therapeutics, Inc.

AKBA · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$0.97
+0.00%
Coverage
Tier 2
Tier 2 · Liquid 3000
SEC CIK
0001517022
Liquidity rank
#2557
Observed dollar volume

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$236.2M2025-12-310001517022-26-000020
Annual diluted EPS-0.022025-12-310001517022-26-000020
Quarterly revenue$49.13M2026-06-300001517022-26-000051
Quarterly diluted EPS-0.032026-06-300001517022-26-000051

SEC EDGAR Frames batch generated 2026-09-08T00:39:23.470Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Dividends

Trailing 12 months
Not published
Latest payment
Not published

Yahoo Finance corporate actions. Window: 2025-09-22 through 2026-09-22.

Seasonality

MonthMean returnPositiven

Monthly close-to-close returns, trailing 15 years where Yahoo history is available.

Sector news

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqBMY · Tier 1 peerDHR · Tier 1 peerMRK · Tier 1 peerPFE · Tier 1 peer

Provenance